Glycated hemoglobin variability and retinopathy progression in type 1 diabetes: Is month-to-moth instability a better predictor?

about

Glucose variability, HbA1c and microvascular complications.

P2860

Q38774291-28744712-9BF9-4D0B-A970-619428629590

P2860

Glycated hemoglobin variability and retinopathy progression in type 1 diabetes: Is month-to-moth instability a better predictor?

Item

http://www.wikidata.org/entity/Q39679038

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Glycated hemoglobin variabilit ...... nstability a better predictor?

@en

Glycated hemoglobin variabilit ...... nstability a better predictor?

@nl

type

Item

label

Glycated hemoglobin variabilit ...... nstability a better predictor?

@en

Glycated hemoglobin variabilit ...... nstability a better predictor?

@nl

prefLabel

Glycated hemoglobin variabilit ...... nstability a better predictor?

@en

Glycated hemoglobin variabilit ...... nstability a better predictor?

@nl

P1476

Glycated hemoglobin variabilit ...... nstability a better predictor?

@en

P2093

Chia-Hsuin Chang

http://www.w3.org/2001/XMLSchema#string

Lee-Ming Chuang

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.

Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT.

HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes.

A1C variability as an independent risk factor for microalbuminuria in young people with type 1 diabetes.

Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes.

A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.

Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature.

Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?

P304

149-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDI.12147

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chia-Hsuin Chang

Lee-Ming Chuang

P577

2013-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260279195

http://www.w3.org/2001/XMLSchema#string

P698

24843754

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

4023577

http://www.w3.org/2001/XMLSchema#string

Glycated hemoglobin variability and retinopathy progression in type 1 diabetes: Is month-to-moth instability a better predictor?

about

P2860

P2860

Glycated hemoglobin variability and retinopathy progression in type 1 diabetes: Is month-to-moth instability a better predictor?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932